Xbiotech announces french national agency (ansm) approval and national cancer institute (insa) funding to support phase i/ii/iii clinical study for natrunix™ in combination with trifluridine/tipiracil (taskin) for treatment of metastatic colorectal cancer

Ansm approves natrunix for insa funded phase-i-iii study at 20 leading medical centers in france ansm approves natrunix for insa funded phase-i-iii study at 20 leading medical centers in france

XBIT Ratings Summary

XBIT Quant Ranking